Fortvita Biologics (usa)inc.

This study is testing whether a new drug called IBI363 works better than standard chemotherapy (docetaxel) for people with advanced squamous non-small cell lung cancer. It's for adults whose cancer has continued to grow despite receiving both platinum-based chemotherapy and immun…

This is a very early study to check if a new drug called IBI3032 is safe for people and to see how the body processes it. It will involve 32 healthy volunteers who will receive a single dose. The main goal is to find a safe dose and understand the drug's basic behavior in the bod…